Zobrazeno 1 - 10
of 52
pro vyhledávání: '"V. Liparulo"'
Autor:
N. Daddi, V. Tassi, E. Scarnecchia, F. Allison, J. Vannucci, R. Capozzi, V. Liparulo, K. Yasufuku, M. De Perrot, A. Pierre, Ö. Mete, R. Colella, S. Ascani, P. Ferolla, G. Darling, S. Keshavjee, F. Puma, T. K. Waddell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4094::a7aaac585b98d57b14aaef66f36cae98
http://hdl.handle.net/11585/664147
http://hdl.handle.net/11585/664147
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
G. Ciccariello, Goffredo Serra, S. Liberali, Carlo Catalano, Andrea Fiorelli, Fulvio Zaccagna, V. Liparulo, Francesco Fraioli, Roberto Passariello
Publikováno v:
La radiologia medica. 116:842-857
Purpose: This study was done to assess the diagnostic potential of dual-source computed tomography (DSCT) in the functional evaluation of lung cancer patients undergoing surgical resection. The CT data were compared with pulmonary perfusion scintigra
Autor:
Marco Anile, Carlo Della Rocca, V. Liparulo, Daniele Diso, Martina Leopizzi, Federico Venuta, Caterina Chiappetta
Publikováno v:
Journal of Circulating Biomarkers, Vol 3, Iss, p 7 (2014)
Journal of Circulating Biomarkers
Volume 3
Issue Godište 2014
Journal of Circulating Biomarkers, Vol 3 (2014)
Journal of Circulating Biomarkers
Volume 3
Issue Godište 2014
Journal of Circulating Biomarkers, Vol 3 (2014)
Objectives: Metastatic recurrence is the most frequent cause of death after surgical resection of lung cancer. Manipulation during surgery has been advocated as one of the causes contributing to promotion of spreading. Methods: We investigated if the
Publikováno v:
Asian cardiovascularthoracic annals. 20(3)
Autor:
T. De Giacomo, Marco Anile, V. Liparulo, Franco Ruberto, Federico Francioni, G. F. Coloni, C. Ricella, Daniele Diso, Erino A. Rendina, Francesco Pugliese, Federico Venuta, M. Rolla, Emanuele Russo
Lung transplantation (LT) represents the only available therapy for selected patients affected by end-stage pulmonary disease. Cardiopulmonary bypass (CPBP) is used, when required, during single and sequential double lung transplantation; however, it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::171894e786f90520aeb20a72d2c19d19
http://hdl.handle.net/11573/225912
http://hdl.handle.net/11573/225912
Publikováno v:
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 34(1)
Autor:
Daniele Diso, Serena Quattrucci, Francesco Pugliese, Federico Francioni, M. Rolla, Federico Venuta, V. Liparulo, M.T. Aratari, C. Ricella, Giancarlo Ferretti, Marco Anile, G. F. Coloni, Sokratis Tsagkaropoulos, T. De Giacomo, M. Di Stasio, Erino A. Rendina
Lung transplantation represents the only therapeutic option for patients affected by end-stage cystic fibrosis (CF). We performed 76 lung transplantations in 73 patients from 1996-2007. The mean time on the waiting list was 10+/-6 months. The median
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94c99cb67dbd21ca6251a790de25380d
http://hdl.handle.net/11573/227556
http://hdl.handle.net/11573/227556
Autor:
Federico Venuta, M. Rolla, T. De Giacomo, Daniele Diso, Marco Anile, M.T. Aratari, Domenico Vitolo, V. Liparulo, M. Di Stasio, Franco Ruberto, G. F. Coloni, C. Ricella, Erino A. Rendina, Flavia Longo
Publikováno v:
Transplantation proceedings. 39(6)
During the last 2 decades, long-term survival after lung transplantation has significantly improved. However, among the complications related to the continuous administration of immunosuppressive drugs, malignancy plays an important role. We retrospe
Autor:
Tiziano De Giacomo, Giorgio F. Coloni, M. Rolla, Mohsen Ibrahim, Marco Anile, V. Liparulo, Federico Venuta, Daniele Diso
Publikováno v:
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 31(4)
Objective:Inductiontherapyfor advancedlungcancerallowsimprovementofcompleteness ofresectionandsurvival.However, predictiverisk factorsforpostoperativecomplicationsandearlymortalityremaincontroversial. Wereportour14-yearexperiencewiththiscombinedappro